SELLAS Life Sciences (SLS) Other Operating Expenses (2011 - 2023)
SELLAS Life Sciences (SLS) reported Other Operating Expenses of $184000.0 for Q1 2023, up 2144.44% year-over-year from $8198.0 in Q1 2022, and up 48.39% quarter-over-quarter from $124000.0 in Q3 2022.
SELLAS Life Sciences (SLS) Other Operating Expenses (2011 - 2023) Analysis & Trends
SELLAS Life Sciences (SLS) has 13 years of Other Operating Expenses data on file, last reported at $184000.0 in Q1 2023.
- Other Operating Expenses for Q1 2023 came in at $184000.0, up 2144.44% year-over-year; the trailing twelve-month figure through Dec 2023 was $184000.0 (down 43.21% YoY), and the FY2022 annual result was $10.1 million, up 71.19% from the prior year.
- Other Operating Expenses improved to $184000.0 in Q1 2023 per SLS's latest filing, from $124000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $5.7 million in Q4 2021 and troughed at -$178000.0 in Q1 2019.
- A 5-year average of $415466.7 and a median of -$18000.0 in 2019 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2021 and 2023: Other Operating Expenses plunged 668.42% in 2021, then jumped 2144.44% in 2023.
- A 5-year view of Other Operating Expenses shows it stood at -$21000.0 in 2019, then jumped by 190.48% to $19000.0 in 2020, then surged by 29900.0% to $5.7 million in 2021, then sank by 97.82% to $124000.0 in 2022, then soared by 48.39% to $184000.0 in 2023.
- Business Quant data shows SLS's Other Operating Expenses at $184000.0 in Q1 2023, $124000.0 in Q3 2022, and $209000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 184,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Jun 30, 2022 | 209,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Dec 31, 2021 | 5.70 Mn |
| Sep 30, 2021 | -108,000.00 |
| Jun 30, 2021 | -160,000.00 |
| Mar 31, 2021 | -158,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | -158,000.00 |
| Mar 31, 2020 | -79,000.00 |
| Dec 31, 2019 | -21,000.00 |
| Sep 30, 2019 | -18,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Mar 31, 2019 | -178,000.00 |
| Dec 31, 2018 | 979,000.00 |
| Sep 30, 2018 | 2.77 Mn |
| Jun 30, 2018 | 602,000.00 |
| Mar 31, 2018 | -2.31 Mn |
| Dec 31, 2017 | -102,000.00 |